The role of phospholipase D in modulating the MTOR signaling pathway in polycystic kidney disease.
The mammalian target of rapamycin (mTOR) signaling pathway is aberrantly activated in polycystic kidney disease (PKD). Emerging evidence suggests that phospholipase D (PLD) and its product phosphatidic acid (PA) regulate mTOR activity. In this study, we assessed in vitro the regulatory function of P...
Guardado en:
Autores principales: | Yang Liu, Andres Käch, Urs Ziegler, Albert C M Ong, Darren P Wallace, Alexandre Arcaro, Andreas L Serra |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a546f237ed6a4c50ac5fabc86144f933 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division
por: Martina Bonucci, et al.
Publicado: (2020) -
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
por: Sachin Hajarnis, et al.
Publicado: (2017) -
Feline Polycystic Kidney Disease: An Update
por: Lorie Schirrer, et al.
Publicado: (2021) -
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
por: Mélissa Carbonneau, et al.
Publicado: (2016) -
Activation of the mTOR signaling pathway is required for asthma onset
por: Yanli Zhang, et al.
Publicado: (2017)